Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPEC with Mitomycin C in Colon Cancer
NCT01167725Phase 3Terminated
- Sponsor
- Cancer and Leukemia Group B
- Start
- Aug 2010
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mitomycin c in colon adenocarcinoma, sponsored by Cancer and Leukemia Group B. Started Aug 2010; status: terminated.
02
Drugs
mitomycin c
03
Conditions
colon adenocarcinoma
Beyond the preview
Go deeper on NCT01167725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01167725.